Share on StockTwits

Express Scripts Holding (NASDAQ:ESRX) was downgraded by research analysts at Monness Crespi & Hardt from a “buy” rating to a “neutral” rating in a report released on Tuesday, reports. The analysts noted that the move was a valuation call.

A number of other analysts have also recently weighed in on ESRX. Analysts at Citigroup Inc. initiated coverage on shares of Express Scripts Holding in a research note on Tuesday. They set a “buy” rating on the stock. Separately, analysts at Jefferson Research upgraded shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research note on Friday. Finally, analysts at Credit Suisse raised their price target on shares of Express Scripts Holding from $75.00 to $83.00 in a research note on Friday, January 17th. Seven investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. Express Scripts Holding presently has an average rating of “Buy” and a consensus price target of $72.94.

Shares of Express Scripts Holding (NASDAQ:ESRX) opened at 76.75 on Tuesday. Express Scripts Holding has a 1-year low of $54.57 and a 1-year high of $76.84. The stock’s 50-day moving average is $73.19 and its 200-day moving average is $66.85. The company has a market cap of $61.846 billion and a price-to-earnings ratio of 34.51.

Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.